Loading...

Loading...

Boehringer Ingelheim's Survodutide Receives FDA Approval
By MBN Staff - Tue, 10/15/2024 - 10:07
Boehringer Ingelheim's survodutide gains FDA Breakthrough Therapy designation for MASH, advancing treatment options.

Partnership Content

Cluster Automotriz Nuevo Leon